Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

20.02
Delayed Data
As of Jul 27
 -0.09 / -0.45%
Today’s Change
7.31
Today|||52-Week Range
20.87
+141.20%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close20.11
Today’s open20.03
Day’s range19.65 - 20.29
Volume556,288
Average volume (3 months)1,134,098
Market cap$960.5M
Dividend yield--
Data as of 3:59pm ET, 07/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-51.56%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio28.4
Price/Sales3.44
Price/Book12.11

Competitors

 Today’s
change
Today’s
% change
FLMLFlamel Technologies ...+0.82+3.45%
XNCRXencor Inc-0.03-0.13%
ZFGNZafgen Inc-1.24-3.41%
ARNAArena Pharmaceutical...-0.06-1.48%
Data as of 4:14pm ET, 07/27/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers